Objective Physical Function in the Alzheimer's Disease Continuum: Association with Cerebrospinal Fluid Biomarkers in the ALBION Study

被引:1
作者
Sampatakakis, Stefanos N. [1 ]
Mamalaki, Eirini [1 ]
Ntanasi, Eva [1 ]
Kalligerou, Faidra [1 ]
Liampas, Ioannis [2 ]
Yannakoulia, Mary [3 ]
Gargalionis, Antonios N. [4 ]
Scarmeas, Nikolaos [1 ,5 ]
机构
[1] Natl & Kapodistrian Univ Athens, Aiginit Hosp, Med Sch, Dept Neurol 1, Athens 11528, Greece
[2] Univ Thessaly, Univ Hosp Larissa, Sch Med, Dept Neurol, Larisa 41100, Greece
[3] Harokopio Univ, Dept Nutr & Diatet, Athens 17671, Greece
[4] Natl & Kapodistrian Univ Athens, Aiginit Hosp, Med Sch, Dept Med Biopathol & Clin Microbiol, Athens 11528, Greece
[5] Columbia Univ, Gertrude H Sergievsky Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Neurol, New York, NY 10032 USA
关键词
walking time; Alzheimer's Disease continuum; cerebrospinal fluid biomarkers; amyloid-beta; 42; MILD COGNITIVE IMPAIRMENT; AMYLOID DEPOSITION; OLDER-ADULTS; RISK-FACTORS; GAIT; BETA; INDIVIDUALS; DEMENTIA; DECLINE; NEURODEGENERATION;
D O I
10.3390/ijms241814079
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cognitive and physical decline, both indicators of aging, seem to be associated with each other. The aim of the present study was to investigate whether physical function parameters (walking time and handgrip strength) are related to cerebrospinal fluid (CSF) biomarkers (amyloid-beta A beta 42, Tau, PhTau) in individuals in the Alzheimer's disease (AD) continuum. The sample was drawn from the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration study, comprising 163 individuals aged 40-75 years: 112 cognitively normal (CN) and 51 with mild cognitive impairment (MCI). Physical function parameters were measured at baseline, a lumbar puncture was performed the same day and CSF biomarkers were analyzed using automated methods. The association between walking time, handgrip strength and CSF biomarkers was evaluated by linear correlation, followed by multivariate linear regression models adjusted for age, sex, education and APOEe4 genotype. Walking time was inversely related to CSF A beta 42 (lower CSF values correspond to increased brain deposition) in all participants (p < 0.05). Subgroup analysis showed that this association was stronger in individuals with MCI and participants older than 60 years old, a result which remained statistically significant after adjustment for the aforementioned confounding factors. These findings may open new perspectives regarding the role of mobility in the AD continuum.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Associations of moderate alcohol intake with cerebrospinal fluid biomarkers of Alzheimer's disease: data from the ALBION study
    Drouka, Archontoula
    Ntetsika, Klairi-Despoina
    Brikou, Dora
    Mamalaki, Eirini
    Ntanasi, Eva
    Chatzipanagiotou, Stylianos
    Gu, Yian
    Scarmeas, Nikolaos
    Yannakoulia, Mary
    EUROPEAN JOURNAL OF NUTRITION, 2025, 64 (03)
  • [2] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Fagan, Anne M.
    Holtzman, David M.
    BIOMARKERS IN MEDICINE, 2010, 4 (01) : 51 - 63
  • [3] Cerebrospinal fluid biomarkers in Alzheimer's disease
    Hugon, Jacques
    Dumurgier, Julien
    Cognat, Emmanuel
    Paquet, Claire
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (1-2): : 307 - 318
  • [4] Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
    Blennow, Kaj
    Zetterberg, Henrik
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (02) : 413 - 417
  • [5] Association of cerebrospinal fluid Neurogranin with Alzheimer's disease
    Wang, Lijun
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 31 (02) : 185 - 191
  • [6] Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1199 - 1209
  • [7] Brain Ventricular Volume and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
    Ott, Brian R.
    Cohen, Ronald A.
    Gongvatana, Assawin
    Okonkwo, Ozioma C.
    Johanson, Conrad E.
    Stopa, Edward G.
    Donahue, John E.
    Silverberg, Gerald D.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (02) : 647 - 657
  • [8] Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study
    Blum, David
    Cailliau, Emeline
    Behal, Helene
    Vidal, Jean-Sebastien
    Delaby, Constance
    Buee, Luc
    Allinquant, Bernadette
    Gabelle, Audrey
    Bombois, Stephanie
    Lehmann, Sylvain
    Schraen-Maschke, Susanna
    Hanon, Olivier
    ALZHEIMERS & DEMENTIA, 2024, 20 (10) : 6948 - 6959
  • [9] Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease
    Petersen, K. K.
    Ezzati, A.
    Lipton, R. B.
    Gordon, B. A.
    Hassenstab, J.
    Morris, J. C.
    Grober, E.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2023, 10 (01): : 112 - 119
  • [10] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Sui, Xiaojing
    Liu, Jianjun
    Yang, Xifei
    NEUROSCIENCE BULLETIN, 2014, 30 (02) : 233 - 242